Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo

被引:15
|
作者
Xie, Qi [1 ]
Wu, Min-Yi [1 ]
Zhang, Ding-Xuan [1 ]
Yang, Yi-Ming [1 ]
Wang, Bao-Shuai [1 ]
Zhang, Jing [2 ]
Xu, Jin [3 ]
Zhong, Wei-De [4 ]
Hu, Jia-Ni [5 ]
机构
[1] Guangzhou Med Univ, Dept Med Imaging, Nansha Cent Hosp, Guangzhou Peoples Hosp 1, Guangzhou 511457, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510080, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Dept Pathol, Guangzhou Peoples Hosp 1, Guangzhou 510180, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Clin Mol Med & Mol Diagnost Lab, Guangzhou Peoples Hosp 1, Guangzhou 510180, Guangdong, Peoples R China
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
Human colon cancer; Multidrug resistance; 5-Fluorouracil; Recombinant adenovirus-mediated p53; Xenografts in nude mice; TUMOR-SUPPRESSOR GENE; COLORECTAL-CANCER; MULTIDRUG-RESISTANCE; THYMIDYLATE SYNTHASE; DRUG-RESISTANCE; BREAST-CANCER; CELL-LINE; 5-FLUOROURACIL; THERAPY; CARCINOMA;
D O I
10.3748/wjg.v22.i32.7342
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate the anticancer effect of a recom-binant adenovirus-mediated p53 (rAd-p53) combined with 5-fluorouracil (5-FU) in human colon cancer resistant to 5-FU in vivo and the mechanism of rAd-p53 in reversal of 5-FU resistance. METHODS Nude mice bearing human colon cancer SW480/5FU (5-FU resistant) were randomly assigned to four groups (n = 25 each): control group, 5-FU group, rAd-p53 group, and rAd-p53 + 5-FU group. At 24 h, 48 h, 72 h, 120 h and 168 h after treatment, 5 mice were randomly selected from each group and sacrificed using an overdose of anesthetics. The tumors were removed and the protein expressions of p53, protein kinase C (PKC), permeability-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) (Western blot) and apoptosis (TUNEL) were determined. RESULTS The area ratios of tumor cell apoptosis were larger in the rAd/p53 + 5-FU group than that in the control, 5-FU and rAd/p53 groups (P < 0.05), and were larger in the rAd/p53 group than that of the control group (P < 0.05) and the 5-FU group at more than 48 h (P < 0.05). The p53 expression was higher in the rAd/p53 and the rAd/p53 + 5-FU groups than that of the control and 5-FU groups (P < 0.05), and were higher in the rAd/p53 + 5-FU group than that of the rAd/p53 group (P < 0.05). Overexpression of PKC, P-gp and MRP1 was observed in the 5-FU and control groups. In the rAd/p53 + 5-FU group, the expression of P-gp and MRP1 was lower that of the control and 5-FU groups (P < 0.05), and the expression of PKC was lower than that of the control, 5-FU and rAd/p53 groups at more than 48 h (P < 0.05). In the rAd/p53 group, the expression of P-gp and MRP1 was lower that of the control and 5-FU groups at more than 48 h (P < 0.05), and the expression of PKC was lower than that of the control and 5-FU groups at more than 120 h (P < 0.05). CONCLUSION 5-FU combined with rAd-p53 has a synergistic anticancer effect in SW480/5-FU (5-FU resistance), which contributes to reversal 5-FU resistance.
引用
收藏
页码:7342 / 7352
页数:11
相关论文
共 50 条
  • [1] Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo
    Qi Xie
    Min-Yi Wu
    Ding-Xuan Zhang
    Yi-Ming Yang
    Bao-Shuai Wang
    Jing Zhang
    Jin Xu
    Wei-De Zhong
    Jia-ni Hu
    World Journal of Gastroenterology, 2016, 22 (32) : 7342 - 7352
  • [2] Effects of wild-type p53 gene transfection and 5-FU administration on cell death in colon cancer cell lines
    Oh, ST
    Kim, HJ
    Kang, WK
    Chang, SK
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 1057 - 1058
  • [3] Combined administration of 5-FU with CDHP exert synergistic antitumor effect for 5-FU resistant gastric cancer cells
    Sasaki, E
    Tominaga, K
    Kuwamura, H
    Watanabe, T
    Fujiwara, Y
    Oshitani, N
    Higuchi, K
    Arakawa, T
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 229 - 231
  • [4] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [5] Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Be17402/5-FU cells
    Li, YX
    Lin, ZB
    Tan, HR
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (01) : 76 - 82
  • [6] Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resiatant human colon carcinoma LoVo/5-FU cells
    Yu, Zhi-Wei
    Zhao, Peng
    Liu, Ming
    Dong, Xin-Shu
    Tao, Ji
    Yao, Xue-Qin
    Yin, Xin-Hua
    Li, Yu
    Fu, Song-Bin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (13) : 1979 - 1983
  • [7] Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resiatant human colon carcinoma LoVo/5-FU cells
    Zhi-Wei Yu Peng Zhao Ming Liu Xin-Shu Dong Department of Abdominal Surgery
    World Journal of Gastroenterology, 2004, (13) : 1979 - 1983
  • [9] 5-fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene
    Osaki, M
    Tatebe, S
    Goto, A
    Hayashi, H
    Oshimura, M
    Ito, H
    APOPTOSIS, 1997, 2 (02) : 221 - 226
  • [10] 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene
    M. Osaki
    S. Tatebe
    A. Goto
    H. Hayashi
    M. Oshimura
    H. Ito
    Apoptosis, 1997, 2 : 221 - 226